Amgen Inc. (AMGN) Q2 2009 Earnings Results

Amgen Beats on EPS, Stock Down 0.25%

Amgen's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.25%. This could suggest that investors were looking for more comprehensive revenue details or future guidance, which were not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.29	N/A	+12.08%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in their product pipeline and ongoing R&D efforts. However, they did not provide specific guidance for future quarters.

Management highlighted strong performance in key therapeutic areas.

They noted ongoing investments in research and development.

There was an emphasis on maintaining a strong pipeline of products.

Amgen Beats on EPS, Stock Down 0.25%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 0.25%

Key numbers

Management commentary